Dr. Reddy’s Of India Buys GSK’s Oral Penicillin Brands, U.S. Plant
This article was originally published in PharmAsia News
Executive Summary
India's Dr. Reddy's Laboratories has purchased the production facility for U.K.-based GlaxoSmithKline's oral penicillin along with rights to its product portfolio